Literature DB >> 8194027

Regression of Kaposi's sarcoma after intravenous immunoglobulin treatment for polymyositis.

Y Carmeli1, D Mevorach, N Kaminski, E Raz.   

Abstract

The authors report on the case of a patient with polymyositis who was given immunosuppressive therapy and then developed Kaposi's sarcoma. Subsequently, the polymyositis was treated with high dose intravenous immunoglobulin, and the Kaposi's sarcoma regressed abruptly. The association between these two diseases and the beneficial effect of intravenous immunoglobulin on Kaposi's sarcoma are discussed.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8194027     DOI： 10.1002/1097-0142(19940601)73:11<2859::aid-cncr2820731132>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  Uncovering the hidden potential of intravenous immunoglobulin as an anticancer therapy.

Authors:  Tal Sapir; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 2.  Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate?

Authors:  L Georgescu; S A Paget
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

Review 3.  Evidence for the use of intravenous immunoglobulins--a review of the literature.

Authors:  Shaye Kivity; Uriel Katz; Natalie Daniel; Udi Nussinovitch; Neophytos Papageorgiou; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

4.  Kaposi's sarcoma in a patient with severe relapsing polychondritis.

Authors:  Mona K Manghani; Jacqueline Andrews; Clare S Higgens
Journal:  Rheumatol Int       Date:  2003-12-05       Impact factor: 2.631

5.  Dermatomyositis complicated with Kaposi sarcoma: a case report.

Authors:  Sara Simeoni; Antonio Puccetti; Sara Moruzzi; Elisa Tinazzi; Dimitri Peterlana; Claudio Lunardi
Journal:  Clin Rheumatol       Date:  2006-01-26       Impact factor: 3.650

6.  Nonspecific immunoglobulin G is effective in preventing and treating cancer in mice.

Authors:  Qian Xu; Zaiping Zhang; Zhiming Chen; Biying Zhang; Chanyuan Zhao; Yimin Zhang; Conghui Zhao; Xiaodong Deng; Yao Zhou; Yanyun Wu; Jiang Gu
Journal:  Cancer Manag Res       Date:  2019-03-07       Impact factor: 3.989
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.